ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Lateral Radiation Therapy Results in Regional Control In Advanced Tonsil Cancer

February 28, 2014

ONF Invites Applications for Fatigue Research

April 19, 1996

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

Program Announcements. RAPID Program Date Change.

June 29, 2001